Longevity & biohacking
CRISPR Age‑Reversal vs Small‑Molecule: The Longevity Battlefield After Cedars‑Sinai
When the lights dimmed at Cedars-Sinai on June 12, 2024, the auditorium felt less like a conference room and more like a coliseum where the future of aging research was about to clash. Over 300 scientists, investors, regulators, and patient-advocates packed the seats, each clutching a copy of the agenda